Mucosal immunization with inactivated HIV-1-capturing nanospheres induces a significant HIV-1-specific vaginal antibody response in mice

Journal of Medical Virology

Volumn 69, Issue 2, 2003, Pages 163-172

  Akagi, Takami ^a   Kawamura, Masaki ^b   Ueno, Masamichi ^a,b   Hiraishi, Katsuya ^a   Adachi, Masakazu ^a   Serizawa, Takeshi ^b   Akashi, Mitsuru ^b   Baba, Masanori ^b  

^a JAPAN IMMUNORESEARCH LABORATORIES   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Estrous cycle; Mucosal IgA; Nasal immunization; Vaccine

Indexed keywords

CON A NS VACCINE; CONCANAVALIN A; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; MEDROXYPROGESTERONE ACETATE; NANOPARTICLE; NEUTRALIZING ANTIBODY; POLYSTYRENE; PROGESTERONE; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; DRUG DELIVERY SYSTEM; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PROPHYLAXIS; SEXUAL INTERCOURSE; VACCINATION; VIRUS PARTICLE; VIRUS TRANSMISSION;

ADMINISTRATION, INTRANASAL; AIDS VACCINES; ANIMALS; ESTRUS; FEMALE; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; IMMUNITY, MUCOSAL; IMMUNIZATION; IMMUNOGLOBULIN A, SECRETORY; MICE; MICROSPHERES; MUCOUS MEMBRANE; NEUTRALIZATION TESTS; VACCINES, INACTIVATED; VAGINA;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 12244273054     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10279     Document Type: Article

References (48)

1. Akashi M, Niikawa T, Serizawa T, Hayakawa T, Baba M. 1998. Capture of HIV-1 gp120 and virions by lectin-immobilized polystyrene nanospheres. Bioconjugate Chem 9:50-53.
2. Alfsen A, Iniguez P, Bouguyon E, Bomsel M. 2001. Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1. J Immunol 166:6257-6265.
3. Balmelli C, Roden R, Potts A, Schiller J, De Grandi P, Nardelli-Haefliger D. 1998. Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions. J Virol 72:8220-8229.
4. Beyrer C, Artenstein AW, Rugpao S, Stephens H, VanCott TC, Robb ML, Rinkaew M, Birx DL, Khamboonruang C, Zimmerman PA, Nelson KE, Natpratan C. 1999. Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group. J Infect Dis 179:59-67.
5. Buge SL, Richardson E, Alipanah S, Markham P, Cheng S, Kalyan N, Miller CJ, Lubeck M, Udem S, Eldridge J, Robert-Guroff M. 1997. An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge. J Virol 71:8531-8541.
6. Burns JW, Siadat-Pajouh M, Krishnaney AA, Greenberg HB. 1996. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 272:104-107.
7. Czerkinsky C, Prince SJ, Michalek SM, Jackson S, Russell MW, Moldoveanu Z, McGhee JR, Mestecky J. 1987. IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans. Proc Natl Acad Sci USA 84:2449-2453.
8. Devito C, Broliden K, Kaul R, Svensson L, Johansen K, Kiama P, Kimani J, Lopalco L, Piconi S, Bwayo JJ, Plummer F, Clerici M, Hinkula J. 2000a. Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells. J Immunol 165:5170-5176.
9. Devito C, Hinkula J, Kaul R, Lopalco L, Bwayo JJ, Plummer F, Clerici M, Broliden K. 2000b. Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate. AIDS 14:1917-1920.
10. Di Tommaso A, Saletti G, Pizza M, Rappuoli R, Dougan G, Abrignani S, Douce G, De Magistris MT. 1996. Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heatlabile enterotoxin as a mucosal adjuvant. Infect Immun 64:974-979.
11. Elson CO, Heck JA, Strober W. 1979. T-cell regulation of murine IgA synthesis. J Exp Med 149:632-643.
12. Foster N, Clark MA, Jepson MA, Hirst BH. 1998. Ulex europaeus 1 lectin targets microspheres to mouse Peyer's patch M-cells in vivo. Vaccine 16:536-541.
13. Gallichan WS, Rosenthal KL. 1996. Effects of the estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex virus type 2 infection in the genital tract. Virology 224:487-497.
14. Gallichan WS, Woolstencroft RN, Guarasci T, McCluskie MJ, Davis HL, Rosenthal KL. 2001. Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract. J Immunol 166:3451-3457.
15. Ghys PD, Belec L, Diallo MO, Ettiegne-Traore V, Becquart P, Maurice C, Nkengasong JN, Coulibaly IM, Greenberg AE, Laga M, Wiktor SZ. 2000. Cervicovaginal anti-HIV antibodies in HIV-seronegative female sex workers in Abidjan, Cote d'Ivoire. AIDS 14:2603-2608.
16. Giannasca PJ, Boden JA, Monath TP. 1997. Targeted delivery of antigen to hamster nasal lymphoid tissue with M-cell-directed lectins. Infect Immun 65:4288-4298.
17. Hayakawa T, Kawamura M, Okamoto M, Baba M, Niikawa T, Takehara S, Serizawa T, Akashi M. 1998. Concanavalin A-immobilized polystyrene nanospheres capture HIV-1 virions and gp120: potential approach towards prevention of viral transmission. J Med Virol 56:327-331.
18. Heritage PL, Underdown BJ, Arsenault AL, Snider DP, McDermott MR. 1997. Comparison of murine nasal-associated lymphoid tissue and Peyer's patches. Am J Respir Crit Care Med 156:1256-1262.
19. Hu J, Gardner MB, Miller CJ. 2000. Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J Virol 74: 6087-6098.
20. Imaoka K, Miller CJ, Kubota M, McChesney MB, Lohman B, Yamamoto M, Fujihashi K, Someya K, Honda M, McGhee JR, Kiyono H. 1998. Nasal immunization of nonhuman primates with simian immunodeficiency virus p55gag and cholera toxin adjuvant induces Th1/Th2 help for virus-specific immune responses in reproductive tissues. J Immunol 161:5952-5958.
21. Jemiolo B, Harvey S, Novotny M. 1986. Promotion of the Whitten effect in female mice by synthetic analogs of male urinary constituents. Proc Natl Acad Sci USA 83:4576-4579.
22. Johansson EL, Rask C, Fredriksson M, Eriksson K, Czerkinsky C, Holmgren J. 1998. Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates. Infect Immun 66:514-520.
23. Kawamura M, Naitou T, Ueno M, Akagi T, Hiraishi K, Takai I, Makino M, Serizawa T, Sugimura K, Akashi M, Baba M. 2002. Induction of mucosal IgA following intravaginal administration of inactivated HIV-1-capturing nanospheres in mice. J Med Virol 66:291-298.
24. King NJ, Parr EL, Parr MB. 1998. Migration of lymphoid cells from vaginal epithelium to iliac lymph nodes in relation to vaginal infection by herpes simplex virus type 2. J Immunol 160:1173-1180.
25. Kurono Y, Yamamoto M, Fujihashi K, Kodama S, Suzuki M, Mogi G, McGhee JR, Kiyono H. 1999. Nasal immunization induces Haemophilus influenzae-specific Th1 and Th2 responses with mucosal IgA and systemic IgG antibodies for protective immunity. J Infect Dis 180:122-132.
26. Lavelle EC, Grant G, Pusztai A, Pfuller U, O'Hagan DT. 2001. The identification of plant lectins with mucosal adjuvant activity. Immunology 102:77-86.
27. Lehner T, Wang Y, Cranage M, Bergmeier LA, Mitchell E, Tao L, Hall G, Dennis M, Cook N, Jones I, Doyle C. 1996. Protective mucosal immunity elicited by targeted lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nat Med 2: 767-775.
28. Letvin NL. 1998. Progress in the development of an HIV-1 vaccine. Science 280:1875-1880.
29. Lu FX, Ma Z, Rourke T, Srinivasan S, McChesney M, Miller CJ. 1999. Immunoglobulin concentrations and antigen-specific antibody levels in cervicovaginal lavages of rhesus macaques are influenced by the stage of the menstrual cycle. Infect Immun 67:6321-6328.
30. Marx PA, Compans RW, Gettie A, Staas JK, Gilley RM, Mulligan MJ, Yamshchikov GV, Chen D, Eldridge JH. 1993. Protection against vaginal SIV transmission with microencapsulated vaccine. Science 260:1323-1327.
31. Mascola JR, Frankel SS, Broliden K. 2000. HIV-1 entry at the mucosal surface: role of antibodies in protection. Science 14:S167-174.
32. Mazzoli S, Trabattoni D, Lo Caputo S, Piconi S, Ble C, Meacci F, Ruzzante S, Salvi A, Semplici F, Longhi R, Fusi ML, Tofani N, Biasin M, Villa ML, Mazzotta F, Clerici M. 1997. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat Med 3:1250-1257.
33. Mazzoli S, Lopalco L, Salvi A, Trabattoni D, Lo Caputo S, Semplici F, Biasin M, Bl C, Cosma A, Pastori C, Meacci F, Mazzotta F, Villa ML, Siccardi AG, Clerici M. 1999. Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons. J Infect Dis 180:871-875.
34. Miller CJ, Hu J. 1999. T cell-tropic simian immunodeficiency virus (SIV) and simian-human immunodeficiency viruses are readily transmitted by vaginal inoculation of rhesus macaques, and Langerhans' cells of the female genital tract are infected with SIV. J Infect Dis 179:S413-417.
35. Milman G, Sharma O. 1994. Mechanisms of HIV/SIV mucosal transmission. AIDS Res Hum Retroviruses 10:1305-1312.
36. Nardelli-Haefliger D, Roden R, Balmelli C, Potts A, Schiller J, De Grandi P. 1999. Mucosal but not parenteral immunization with purified human papillomavirus type 16 virus-like particles induces neutralizing titers of antibodies throughout the estrous cycle of mice. J Virol 73:9609-9613.
37. Parr MB, Parr EL. 1990. Antigen recognition in the female reproductive tract: I. Uptake of intraluminal protein tracers in the mouse vagina. J Reprod Immunol 17:101-114.
38. Parr MB, Kepple L, McDermott MR, Drew MD, Bozzola JJ, Parr EL. 1994. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Lab Invest 70: 369-380.
39. Renegar KB, Jackson GD, Mestecky J. 1998. In vitro comparison of the biologic activities ofmonoclonal monomeric IgA, polymeric IgA, and secretory IgA. J Immunol 160:1219-1223.
40. Sonoda Y, Mukaida N, Wang JB, Shimada-Hiratsuka M, Naito M, Kasahara T, Harada A, Inoue M, Matsushima K. 1998. Physiologic regulation of postovulatory neutrophil migration into vagina in mice by a C-X-C chemokine(s). J Immunol 160:6159-6165.
41. Spira AI, Marx PA, Patterson BK, Mahoney J, Koup RA, Wolinsky SM, Ho DD. 1996. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med 183:215-225.
42. Staats HF, Nichols WG, Palker TJ. 1996. Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A). J Immunol 157:462-472.
43. Staats HF, Montgomery SP, Palker TJ. 1997. Intranasal immunization is superior to vaginal, gastric, or rectal immunization for the induction of systemic and mucosal anti-HIV antibody responses. AIDS Res Hum Retroviruses 13:945-952.
44. Stanisz AM, Befus D, Bienenstock J. 1986. Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen. J Immunol 136:152-156.
45. VanCott TC, Kaminski RW, Mascola JR, Kalyanaraman VS, Wassef NM, Alving CR, Ulrich JT, Lowell GH, Birx DL. 1998. HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160. J Immunol 160: 2000-2012.
46. van Egmond M, Damen CA, van Spriel AB, Vidarsson G, van Garderen E, van de Winkel JG. 2001. IgA and the IgA Fc receptor. Trends Immunol 22:205-211.
47. Wu HY, Abdu S, Stinson D, Russell MW. 2000. Generation of female genital tract antibody responses by local or central (common) mucosal immunization. Infect Immun 68:5539-5545.
48. Zinckgraf JW, Winchell JM, Silbart LK. 1999. Antibody responses to a mucosally delivered HIV-1 gp120-derived C4/V3 peptide. J Reprod Immunol 45:99-112.